190 related articles for article (PubMed ID: 2012353)
1. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone.
Bruns FJ; Adler S; Fraley DS; Segel DP
Ann Intern Med; 1991 May; 114(9):725-30. PubMed ID: 2012353
[TBL] [Abstract][Full Text] [Related]
2. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
Reichert LJ; Huysmans FT; Assmann K; Koene RA; Wetzels JF
Ann Intern Med; 1994 Sep; 121(5):328-33. PubMed ID: 8042821
[TBL] [Abstract][Full Text] [Related]
3. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy.
Smith MC; Austen JL; Carey JT; Emancipator SN; Herbener T; Gripshover B; Mbanefo C; Phinney M; Rahman M; Salata RA; Weigel K; Kalayjian RC
Am J Med; 1996 Jul; 101(1):41-8. PubMed ID: 8686713
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
[TBL] [Abstract][Full Text] [Related]
5. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
Bitencourt Dias C; Pinheiro CC; Malafronte P; Titan S; Alves de Brito G; Gera Abrão J; Dos Santos Silva V; Toledo Barros R; Woronik V
Clin Nephrol; 2011 Jul; 76(1):57-63. PubMed ID: 21722606
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis.
West ML; Jindal KK; Bear RA; Goldstein MB
Kidney Int; 1987 Oct; 32(4):579-84. PubMed ID: 3323596
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
Cortazar FB; Leaf DE; Owens CT; Laliberte K; Pendergraft WF; Niles JL
BMC Nephrol; 2017 Feb; 18(1):44. PubMed ID: 28143416
[TBL] [Abstract][Full Text] [Related]
8. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
Ponticelli C; Altieri P; Scolari F; Passerini P; Roccatello D; Cesana B; Melis P; Valzorio B; Sasdelli M; Pasquali S; Pozzi C; Piccoli G; Lupo A; Segagni S; Antonucci F; Dugo M; Minari M; Scalia A; Pedrini L; Pisano G; Grassi C; Farina M; Bellazzi R
J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
[No Abstract] [Full Text] [Related]
13. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.
Levey AS; Lan SP; Corwin HL; Kasinath BS; Lachin J; Neilson EG; Hunsicker LG; Lewis EJ
Ann Intern Med; 1992 Jan; 116(2):114-23. PubMed ID: 1727614
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
15. Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network.
Falk RJ; Hogan SL; Muller KE; Jennette JC
Ann Intern Med; 1992 Mar; 116(6):438-45. PubMed ID: 1371211
[TBL] [Abstract][Full Text] [Related]
16. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency.
Branten AJ; Reichert LJ; Koene RA; Wetzels JF
QJM; 1998 May; 91(5):359-66. PubMed ID: 9709470
[TBL] [Abstract][Full Text] [Related]
17. Membranous glomerulonephritis: treatment response and outcome in children.
Valentini RP; Mattoo TK; Kapur G; Imam A
Pediatr Nephrol; 2009 Feb; 24(2):301-8. PubMed ID: 18846392
[TBL] [Abstract][Full Text] [Related]
18. Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.
Zonozi R; Laliberte K; Huizenga NR; Rosenthal JK; Jeyabalan A; Collins AB; Cortazar FB; Niles JL
Am J Kidney Dis; 2021 Dec; 78(6):793-803. PubMed ID: 34174365
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy.
Alexopoulos E; Sakellariou G; Memmos D; Karamitsos K; Leontsini M; Papadimitriou M
Am J Kidney Dis; 1993 May; 21(5):497-503. PubMed ID: 8488817
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
